Risk of bronchospasm and coronary arteriospasm with sugammadex use: a post marketing analysis.
Aggarwal P.
Ther Adv Drug Saf. 2019 Aug 18;10:2042098619869077. doi: 10.1177/2042098619869077. eCollection 2019.
PMID:31452867
[Traumatic arteriospasm].
KOLODZIEJ J.
Pol Przegl Chir. 1956 Jul;28(7):675-6.
PMID:13388754
Severe peripheral arteriospasm following oxytocin administration.
Evron S, Ariely S, Agasi M, Eger G, Bukovsky I, Caspi E.
Am J Obstet Gynecol. 1986 Sep;155(3):657-8. doi: 10.1016/0002-9378(86)90299-1.
PMID:3752184
ARTERIOSPASM AFTER ERGOTAMINE TARTRATE.
SUTTON RA.
Br Med J. 1964 Sep 19;2(5411):756-7. doi: 10.1136/bmj.2.5411.756-c.
PMID:14172050
[Arteriospasm in ictus].
Pierantozzi N.
Dtsch Med Wochenschr. 1971 Oct 15;96(42):1650.
PMID:5142765
Dexmedetomidine: a real-world safety analysis based on FDA adverse event reporting system database.
Shuai Y, Chen Z, Wan Q, Wu J, Wang X.
Front Pharmacol. 2024 Aug 23;15:1419196. doi: 10.3389/fphar.2024.1419196. eCollection 2024.
PMID:39246655
PROLONGED ARTERIOSPASM AFTER ERGOTAMINE.
CAMERON EA, FRENCH EB.
Br Med J. 1964 Oct 3;2(5413):875-6. doi: 10.1136/bmj.2.5413.875-d.
PMID:14191893
Retinal arteriospasm in polycythemia vera.
NILSSON LB, RENDAHL I, STROMBERG HE.
Am J Ophthalmol. 1958 Mar;45(3):358-64. doi: 10.1016/0002-9394(58)90816-x.
PMID:13508808
[CEREBRAL ARTERIOSPASM. CASE REPORT AND RADIOLOGIC CONTRIBUTION TO THE PROBLEM OF THE EXISTENCE OF CEREBRAL ARTERIAL SPASMS AND THEIR SIGNIFICANCE FOR THE PATHOGENESIS OF THE ISCHEMIC INSULTUS].